RT Journal Article
T1 [Primary care evaluation of the hypertensive patient management in specialized care after derivation (DERIVA-2 Study)].
T2 Valoración desde atención primaria del manejo del hipertenso en atención especializada (estudio DERIVA-DOS).
A1 Martell-Claros, Nieves
A1 Galgo Nafría, Alberto
A1 Abad-Cardiel, María
A1 Álvarez-Álvarez, Beatriz
A1 García Donaire, José Antonio
A1 Márquez-Contreras, Emilio
A1 Molino-González, Ángel
K1 Atención especializada en hipertensión
K1 Coordinación entre niveles
K1 Coordination between health-care levels
K1 Derivación
K1 Derivation
K1 Hipertensión
K1 Hypertension
K1 Niveles de atención de salud: Atención primaria
K1 Primary care
K1 Specializing in hypertension care
AB To know the opinion/evaluation of the primary care physicians (PCPH) of the received information about patients that were attended in specialized care (SC). Cross-sectional study. Performed nationwide in primary care centers. Researchers from the primary care network. We used the SEH-LELHA derivation criteria guidelines, plus an ad hoc survey that included demographic and anthropometric data, blood pressure levels, and the main reason for derivation to SC at the baseline and final (post-derivation) visit. In addition, time deployed for the study of every patient, changes in diagnosis and treatment, type of follow-up, issues throughout the derivation process and assessment of the medical referred to the PCPH were evaluated. With participation of 578 researchers from primary, the study included 1715 patients aged 60.7±13.3years, 62.7% male. Patients were taking 2.3±1.2 (range 0-10) antihypertensive drugs pre-referral and 2.5±1.2 (0-9) after derivation. Blood pressure levels changed from 166±21.6 /97.7±12.6mmHg to 143±14.4 /85.5±10.5mmHg. The number of controlled patients (BP Communication between AE and SC in HTA is valued satisfactorily by MAP. However there is still room for improvement in the process.
YR 2017
FD 2017-10-14
LK http://hdl.handle.net/10668/11689
UL http://hdl.handle.net/10668/11689
LA es
DS RISalud
RD Apr 9, 2025